The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...

For adults with type 1 diabetes, a regimen of inhaled Technosphere insulin (TI) plus insulin degludec is noninferior to usual ...

Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...

Call planned today at 8:30 a.m. (ET) to discuss company's diabetes program progression The INHALE-1 study is a 26-week, ...

From life-changing medical advancements to colorful auroras, this year has been packed with incredible science. It was hard ...

MannKind today announced six-month results from its Phase 3 INHALE-1 study of Afrezza insulin inhalation powder in children.

Despite this, the mITT analysis supported Afrezza’s non-inferiority to multiple daily injections (MDI) of rapid-acting ...

Technological advances have profoundly affected people living with type 1 diabetes, their families or carers, and health-care ...

(RTTNews) - MannKind Corporation (MNKD) Monday reported positive six-month results from its Phase 3 INHALE-1 study of Afrezza Inhalation Powder, a rapid-acting inhaled human insulin, in individuals ...

MannKind (MNKD) announced six-month results from its Phase 3 INHALE-1 study of Afrezza Inhalation Powder in children and adolescents. MannKind ...

Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not ...

But if your child is suddenly drowsier than usual, is frequently thirsty, gets tired easily and loses weight drastically, ...